Crossmark

Finerenone: a breakthrough mineralocorticoid receptor antagonist for heart failure, diabetes and chronic kidney disease

Published Online: 2024-12-16

Authors

Pradhan, Akshyaya

Tripathi, Umesh Chandra https://orcid.org/0000-0002-3113-6766
License Information

Text and Data Mining valid from 2024-12-16

Version of Record valid from 2024-12-16
More Information

Article History

Received: 18 June 2024

Accepted: 13 November 2024

First Online: 16 December 2024

Declarations

:

: Not applicable.

: Not applicable..

: The authors declare that they have no competing interests.

Document is current